Pfizer to pay $2.26B for cancer treatment developer Trillium
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay $18.50 for each share of Trillium...
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay $18.50 for each share of Trillium...